History

Charting
Our Journey

2024

Polyamyna and NLHS innovation team initiating a patient-facing clinical trial to demonstrate Keep Klear’s effectiveness against multidrug-resistant pathogens in patient-facing post-surgical medicine wards. The goal is to demonstrate that Keep Klear protected surface significantly reduces the pathogen burden on a large variety of environmental surfaces in vulnerable patient groups​

2024

Polyamyna in concrete with W21C in Calgary are focused on human factors trial to refine the Keep Klear offering by the evaluation of Keep Klear’s journey of innovation for commercialization

2024

PNI successfully completes an operational integration trial of Keep Klear, a stress-testing initiative, in high-traffic healthcare bathrooms and waiting areas. The results were extremely encouraging.

2023

Polyamyna has completed a non-patient-facing integration of Keep Klear to demonstrate the non-impact of intervention when used with routine cleaning and operations in the healthcare clinical setting

2023

PNI is happy to announce the addition of Al Dillion to our team with a focus on PNI technology for healthcare and other key problem areas for the Department of Defense in Canada

2023

Polyamyna engaged with US-EPA regarding the new regulatory process for the ability to claim residual activity and has successfully passed the maximum residual claim requirements for supplemental coatings and these claims have been accepted by Health Canada

2023

PNI performs 3rd party evaluation of health economics for the cost of infections in Canada for nosocomial infections, highlighting the tremendous burden of methicillin-resistant S.A (MRSA) and Clostridium difficle (C.Diff)

2023

PNI welcomes non-dilutive investment with the Department of Industry, Energy & Technology of the Provincial Government of Newfoundland & Labrador for 523K to support the clinical trials without partner health authority Newfoundland & Labrador Health Services (NLHS)

2022

PNI is happy to announce the joining of Dr. Zhanel, Director of the Canadian Antimicrobial Resistance Alliance  (CARA) and Premier of Newfoundland & Labrador Dwight Ball 2013-2019 to our Advisory Team 

2022

Chris Simpson, President and Founder of Canada Clean Room joined as Advisor

2021

PNI opens R&D facility in Chennai India, Ticel Biopark II

2021

Keep Klear Health Canada Pest Management Regulatory Agency application filed ​